PRICE T ROWE ASSOCIATES INC /MD/
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 80255
BALTIMORE, MD
Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$926,862
+$299,697 QoQ
Shares Held
93,528
-8.6% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. DNA ranks #177 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in DNA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $926,862 | 93,528 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $627,165 | 102,311 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $788,394 | 94,873 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,355,997 | 93,004 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $988,795 | 87,893 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $423,395 | 74,280 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $813,242 | 82,815 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $649,253 | 79,663 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,001,258 | 2,997,781 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,825,946 | 3,298,230 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,859,405 | 3,467,104 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $6,239,282 | 3,447,118 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,388,969 | 3,434,930 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,640,198 | 3,488,871 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,859,460 | 4,058,853 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,153,639 | 4,215,910 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,971,340 | 4,189,639 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $35,589,647 | 8,831,178 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,858,331 | 2,269,354 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,383,121 | 291,900 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||